 |
|
Jaundice Noted in the First 24 Hours After Birth in a Managed Care Organization
Thomas B. Newman, MD, MPH;
Petra Liljestrand, PhD;
Gabriel J. Escobar, MD
Arch Pediatr Adolesc Med. 2002;156:1244-1250.
Objective To investigate the significance of jaundice noted in the first 24 hours after birth in a community setting.
Design Supplementary analyses of a nested case-control study.
Setting Northern California Kaiser Permanente Medical Care Program.
Patients Six hundred thirty-one randomly selected newborns (controls) and 140 cases with total serum bilirubin levels of 25 mg/dL (428 µmol/L) or higher from a cohort of 105 384 newborns of at least 2000 g birth weight and at least 36 weeks' gestational age, born between January 1, 1995, and December 31, 1998.
Main Outcome Measures Notations of jaundice in the medical record, timing and results of bilirubin testing, use of phototherapy, and development of bilirubin levels of 25 mg/dL or higher.
Results Among the controls, the cumulative probability of a notation of jaundice (corrected for early hospital discharge using survival analysis) was 2.8% within 18 hours and 6.7% within 24 hours. In these newborns, cumulative proportions that had bilirubin levels measured were 38% within 12 hours and 43% within 24 hours of when jaundice was first noted. About 40% of bilirubin levels measured within 24 hours were above the estimated 95th percentile for age. Compared with newborns not noted to be jaundiced on the first day, newborns noted to be jaundiced within 24 hours were more likely to receive phototherapy (18.9% vs 1.7%; relative risk, 10.1; 95% confidence interval, 4.2-24.4) and to develop a bilirubin level of 25 mg/dL or higher (odds ratio, 2.9; 95% confidence interval, 1.6-5.2), but the absolute risk increase for total serum bilirubin levels of 25 mg/dL or higher was 0.2%.
Conclusion Jaundice noted in the medical record in the first 24 hours after birth was uncommon and often clinically significant in this setting, but other factors also need to be considered in determining its importance.
From the Departments of Epidemiology and Biostatistics (Drs Newman and Liljestrand) and Pediatrics (Dr Newman), School of Medicine, The University of California, San Francisco; Division of Research, Kaiser Permanente Medical Care Program, Oakland (Drs Newman, Liljestrand, and Escobar); and Department of Pediatrics, Kaiser Permanente Medical Center, Walnut Creek (Dr Escobar), Calif.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Combining Clinical Risk Factors With Serum Bilirubin Levels to Predict Hyperbilirubinemia in Newborns
Newman et al.
Arch Pediatr Adolesc Med 2005;159:113-119.
ABSTRACT
| FULL TEXT
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Subcommittee on Hyperbilirubinemia
Pediatrics 2004;114:297-316.
ABSTRACT
| FULL TEXT
Infants With Bilirubin Levels of 30 mg/dL or More
Kaplan et al.
Pediatrics 2004;113:429-430.
FULL TEXT
|
